Anthem Blue Cross and Blue Shield New Hampshire prior authorization, page 12

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
0539UOncology (solid tumor), cell-free circulatinNew Hampshire Precertification List, Pg 61 Original policy
0540TChimeric antigen receptor T-cell (CAR-T) therapy; CAR-T cell administration, autologousNew Hampshire Precertification List, Pg 61 Original policy
0540UTransplantation medicine, quantification oNew Hampshire Precertification List, Pg 61 Original policy
0541UCardiovascular disease (HDL reverse choNew Hampshire Precertification List, Pg 61 Original policy
0543UOncology (solid tumor), next-generation sNew Hampshire Precertification List, Pg 61 Original policy
0544TTranscatheter mitral valve annulus reconstruction, with implantation of adjustable annulus reconstruction device, percutaneous approach including transseptal punctureNew Hampshire Precertification List, Pg 61 Original policy
0544UNephrology (transplant monitoring), 48 varNew Hampshire Precertification List, Pg 61 Original policy
0545TTranscatheter tricuspid valve annulus reconstruction with implantation of adjustable annulus reconstruction device, percutaneous approachNew Hampshire Precertification List, Pg 61 Original policy
0546TRadiofrequency spectroscopy, real time, intraoperative margin assessment, at the time of partial mastectomy, with reportNew Hampshire Precertification List, Pg 61 Original policy
0549UOncology (urothelial), DNA, quantitative mNew Hampshire Precertification List, Pg 61 Original policy
0550UOncology (prostate), enzyme-linked immuNew Hampshire Precertification List, Pg 62 Original policy
0552TLow-level laser therapy, dynamic photonic and dynamic thermokinetic energies, provided by a physician or other qualified health care professionalNew Hampshire Precertification List, Pg 62 Original policy
0552UReproductive medicine (preimplantation gNew Hampshire Precertification List, Pg 62 Original policy
0553UReproductive medicine (preimplantation gNew Hampshire Precertification List, Pg 62 Original policy
0554UReproductive medicine (preimplantation gNew Hampshire Precertification List, Pg 62 Original policy
0555UReproductive medicine (preimplantation gNew Hampshire Precertification List, Pg 62 Original policy
0560UOncology (minimal residual disease [MRDNew Hampshire Precertification List, Pg 62 Original policy
0561UOncology (minimal residual disease [MRDNew Hampshire Precertification List, Pg 62 Original policy
0562UOncology (solid tumor), targeted genomicNew Hampshire Precertification List, Pg 62 Original policy
0563TEvacuation of meibomian glands, using heat delivered through wearable, open- eye eyelid treatment devices and manual gland expression, bilateralNew Hampshire Precertification List, Pg 62 Original policy
0565TAutologous cellular implant derived from adipose tissue for the treatment of osteoarthritis of the knees; tissue harvesting and cellular implant creationNew Hampshire Precertification List, Pg 62 Original policy
0565UOncology (hepatocellular carcinoma), nextNew Hampshire Precertification List, Pg 62 Original policy
0566TAutologous cellular implant derived from adipose tissue for the treatment of osteoarthritis of the knees; injection of cellular implant into knee joint including ultrasound guidance, unilateralNew Hampshire Precertification List, Pg 62 Original policy
0566UOncology (lung), qPCR-based analysis ofNew Hampshire Precertification List, Pg 62 Original policy
0567URare diseases (constitutional/heritable disNew Hampshire Precertification List, Pg 62 Original policy
0569TTranscatheter tricuspid valve repair, percutaneous approach; initial prosthesisNew Hampshire Precertification List, Pg 62 Original policy
0569UOncology (solid tumor), next-generation sNew Hampshire Precertification List, Pg 62 Original policy
0571TInsertion or replacement of implantable caNew Hampshire Precertification List, Pg 62 Original policy
0571UOncology (solid tumor), DNA (80 genes) aNew Hampshire Precertification List, Pg 62 Original policy
0572TInsertion of substernal implantable defibrillNew Hampshire Precertification List, Pg 62 Original policy
0573TRemoval of substernal implantable defibrillNew Hampshire Precertification List, Pg 62 Original policy
0574TRepositioning of previously implanted subNew Hampshire Precertification List, Pg 62 Original policy
0575UTransplantation medicine (liver allograft rejection), miRNA gene expression profiling by RT-PCR of 4 genes (miR- 122, miR-885, miR-23a housekeeping, spike-in control), serum, aNew Hampshire Precertification List, Pg 62 Original policy
0576UTransplantation medicine (liver allograft rejection), quantitative donor-derived cell- free DNA (cfDNA) by whole genome next- generation sequencing, plasma and mRNA gene expressNew Hampshire Precertification List, Pg 62 Original policy
0578UOncology (cutaneous melanoma), RNA, gene expression profiling by real-time qPCR of 10 genes (8 content and 2 housekeeping), utilizing formalin-fixed paraffin-embedded (FFPE) tNew Hampshire Precertification List, Pg 62 Original policy
0580TRemoval of substernal implantable defibrillNew Hampshire Precertification List, Pg 62 Original policy
0581TAblation, malignant breast tumor(s), percutaneous, cryotherapy, including imaging guidance when performed, unilateralNew Hampshire Precertification List, Pg 63 Original policy
0582URare diseases (constitutional disease/hereditary disorders), rapid whole genome DNA sequencing for single-nucleotide variants, insertions/deletions, copy number variations, blNew Hampshire Precertification List, Pg 63 Original policy
0583URare diseases (constitutional disease/hereditary disorders), rapid whole genome comparator DNA sequencing for single-nucleotide variants, insertions/deletions, copy number varNew Hampshire Precertification List, Pg 63 Original policy
0584TIslet cell transplant, includes portal vein catheterization and infusion, including all imaging, including guidance, and radiological supervision and interpretation, when performed; percutaneousNew Hampshire Precertification List, Pg 63 Original policy
0585TIslet cell transplant, includes portal vein catheterization and infusion, including all imaging, including guidance, and radiological supervision and interpretation, when performed; laparoscopicNew Hampshire Precertification List, Pg 63 Original policy
0585UTargeted genomic sequence analysis panel, solid organ neoplasm, circulating cell-free DNA (cfDNA) analysis from plasma of 521 genes, interrogation for sequence variants, geneNew Hampshire Precertification List, Pg 63 Original policy
0586TIslet cell transplant, includes portal vein catheterization and infusion, including all imaging, including guidance, and radiological supervision and interpretation, when performed; openNew Hampshire Precertification List, Pg 63 Original policy
0586UOncology, mRNA, gene expression profiling of 216 genes (204 targeted and 12 housekeeping genes), RNA expression analysis, formalin-fixed paraffin-embedded (FFPE) tissue, quantNew Hampshire Precertification List, Pg 63 Original policy
0587TPercutaneous implantation or replacement of integrated single device neurostimulation system for bladder dysfunction including electrode array and receiver or pulse generator, including analysis, programming, and imaging guidance when performed, posterior tibial nerveNew Hampshire Precertification List, Pg 63 Original policy
0588TRevision or removal of percutaneously placed integrated single device neurostimulation system for bladder dysfunction including electrode array and receiver or pulse generator, including analysis, programming, and imaging guidance when performed, posterior tibial nerveNew Hampshire Precertification List, Pg 64 Original policy
0589UPerfluoroalkyl substances (PFAS) (eg, perfluorooctanoic acid, perfluorooctane sulfonic acid), 24 PFAS compounds by high-performance liquid chromatography with tandem mass specNew Hampshire Precertification List, Pg 64 Original policy
0592UOncology (hematolymphoid neoplasms), DNA, targeted genomic sequence of 417 genes, interrogation for gene fusions, translocations, rearrangements, utilizing formalin-fixed paraNew Hampshire Precertification List, Pg 64 Original policy
0596TTemporary female intraurethral valve- pump (ie, voiding prosthesis); initial insertion, including urethral measurementNew Hampshire Precertification List, Pg 64 Original policy
0597TTemporary female intraurethral valve- pump (ie, voiding prosthesis); replacementNew Hampshire Precertification List, Pg 64 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.